Logo
x

Search category

Subscribe Now

Co-Development

Coave Signs an Exclusive License Agreement with Théa to Co-Development and Commercialize CTx-PDE6b for PDE6b Associated Retinitis Pigmentosa in EU

Coave Signs an Exclusive License Agreement with Théa to Co-Development and Commercialize CTx-PDE6b for PDE6b Associated Retinitis...

  • September 17, 2021
Eisai Collaborates with BMS for the Co-Development and Co-Commercialization of MORAb-202

Eisai Collaborates with BMS for the Co-Development and Co-Commercialization of MORAb-202

  • June 21, 2021
Onward Signs a Worldwide Exclusive License and Co-Development Agreement with Biomunex for Immuno-Oncology

Onward Signs a Worldwide Exclusive License and Co-Development Agreement with Biomunex for Immuno-Oncology

  • February 16, 2021
Oncolytics Biotech Signs a Clinical Trial Collaboration with Merck KGaA and Pfizer

Oncolytics Biotech Signs a Clinical Trial Collaboration with Merck KGaA and Pfizer

  • June 6, 2019
BeiGene Signs a Worldwide Co-Development and Commercialization Agreement with BioAtla for BA3071 and Tislelizumab

BeiGene Signs a Worldwide Co-Development and Commercialization Agreement with BioAtla for BA3071 and Tislelizumab

  • April 9, 2019
Takeda Globally Signs Licensing- Co-Development & Co-Promotion Agreement with Enterome for its EB8018 Candidate

Takeda Globally Signs Licensing- Co-Development & Co-Promotion Agreement with Enterome for its EB8018 Candidate

  • October 24, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.